Researchers develop new method to culture norovirus in intestinal cells

NewsGuard 100/100 Score

WHAT:

Researchers have succeeded in culturing norovirus in human intestinal cells, a breakthrough that could help scientists develop novel therapeutics and vaccines against the debilitating effects of the virus. Intestinal cells are the natural site of norovirus infection, a leading cause of foodborne illness that is highly contagious and can produce sudden onset stomach pain, nausea, diarrhea and vomiting. In the United States, norovirus infection results in about 400,000 emergency department visits and as many as 71,000 hospitalizations annually, mostly among young children and the elderly, according to the U.S. Centers for Disease Control and Prevention. The virus spreads easily in closed and crowded environments such as hospitals, schools and cruise ships.

Norovirus was first identified in 1972 at the National Institutes of Health (NIH) by Albert Z. Kapikian, M.D., and colleagues. However, study of the virus has been difficult because of researchers' inability to grow the virus outside the human body and the lack of a good animal model to study infection and disease. This has limited knowledge of the basic biology of the virus, including aspects of the molecular mechanisms behind how it causes people to become ill.

To overcome this gap, investigators at Baylor College of Medicine engineered human intestinal tissue from stem cells isolated from the small intestine. When the researchers infected the cultured gut tissue with different strains of norovirus, some virus strains grew well in the cells while others did not. To promote virus growth, the team then tried adding bile from humans and other animals, including cows and pigs, to the intestinal cells. Researchers found that bile was required for replication of some virus strains and enhanced the growth of other strains in the cells. The authors say this new cultivation method could have applications for food safety and the development of new diagnostics, vaccines and therapeutics for norovirus.

Source:

NIH/National Institute of Allergy and Infectious Diseases

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Measles and rubella vaccine delivered via microarray patch shows promising results